Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × FED × pembrolizumab × Clear all

Phase

Phase 2 3 Phase 1/2 1 Phase 1 1

Status

Sponsor Class

INDUSTRY 261 OTHER 164 NIH 11 OTHER_GOV 2 UNKNOWN 1 NETWORK 1 INDIV 1 FED 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 1

Interventions

sargramostim 1 pembrolizumab 1 Injections 1 Granulocyte-Macrophage Colony-Stimulating Factor 1 Exercise 1 Cryotherapy 1 Cryosurgery 1 Clofarabine 1 Celecoxib 1 Capecitabine 1 ADI PEG20 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05430009 2022-08-01

Liver SBRT in Combination With Immune Checkpoint Inhibition in Patients With Metastatic Non-small Cell Lung Cancer

VA Ann Arbor Healthcare System

Phase 1 Recruiting

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon ⚡